The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Benzodiazepines: Risks and benefits. A reconsideration
Open accessAbstract
Over the last decade there have been further developments in our knowledge of the risks and benefits of benzodiazepines, and of the risks and benefits of alternatives to benzodiazepines. Representatives drawn from the Psychopharmacology Special Interest Group of the Royal College of Psychiatrists and the British Association for Psychopharmacology together examined these developments, and have provided this joint statement with recommendations for clinical practice. The working group was mindful of widespread concerns about benzodiazepines and related anxiolytic and hypnotic drugs. The group believes that whenever benzodiazepines are prescribed, the potential for dependence or other harmful effects must be considered. However, the group also believes that the risks of dependence associated with long-term use should be balanced against the benefits that in many cases follow from the short or intermittent use of benzodiazepines and the risk of the underlying conditions for which treatment is being provided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They have been shown to be effective in the acute treatment of generalized anxiety disorder, social anxiety, panic disorder, and insomnia [8].”
Citations
Cites
Wilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110379307 · Cited by 634
Self-citationBaldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
Self-citationLingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
Self-citationDell’osso, B., & Lader, M. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2011.11.003 · Cited by 210
Uncritical positive regard? Issues in the efficacy and safety of psychotherapy
Nutt, D. J., & Sharpe, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107086283 · Cited by 123
Self-citationSubstitution therapy for alcoholism: time for a reappraisal?
Chick, J., & Nutt, D. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408463 · Cited by 80
Self-citationNeuropharmacology of Benzodiazepines
Stephens, D., & King, S. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398335-0.00059-5 · Cited by 2
Self-citation
Cited by
Sorted by citations
Items 201–250 of 250
Prescribing and Dispensing of Benzodiazepines
Islam, M. M., Nielsen, S., McRae, I., Haber, P., Demirkol, A., Murnion, B. P., Wilson, H. H., & Conigrave, K. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00028-7
Epidemiological studies of medication use and effectiveness in bipolar disorder
Wingård, L. (2017) · Figshare
Panico: nosografia di un'entità, clinica di un disturbo
Mancuso, F., Marucco, D. A., Vivo, E. D., Bellinato, M., Desantis, G., Gramoni, A., Pini, D., Zeme, D., & Bignamini, E. (2017) · MISSION · doi:10.3280/mis48-2016oa4726
Poorter, A. (2017) · UTAS Research Repository · doi:10.25959/23239763
Using sedatives–hypnotics or opioids in older adults: a narrow path
Davies, S., & Mulsant, B. H. (2018) · International Psychogeriatrics · doi:10.1017/s104161021800087x
Self-citationA Durable Minimal Intervention Strategy to Reduce Benzodiazepine Use in a Primary Care Population
Davidson, S., Thomson, C., & Prescott, G. J. (2019) · Korean Journal of Family Medicine · doi:10.4082/kjfm.18.0159
Experimental Medicine Models in Generalized Anxiety Disorder and Social Anxiety Disorder
Baldwin, D. S., & Abou-Aisha, A. (2019) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-803161-2.00025-4 · Cited by 1
Self-citationDavies, S., & Mulsant, B. H. (2020) · International Psychogeriatrics · doi:10.1017/s1041610219000760
Self-citationBenzodiazepine Receptors in the Periphery
Raffa, R. B. (2020) · doi:10.1093/med/9780197517277.003.0006
Anxiolytics: Misuse, Dependence, and Withdrawal Syndromes
Tang, V. M., & Davies, S. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_405-1
Self-citationChen, Y., Wang, F., Cui, L., Huang, H., Kong, S., Qian, N., Zhang, M., Lyu, D., Wang, M., Liu, X., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-394328/v1
Drago, F., & Caraci, F. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732500679.793576055
Stark, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-29462-5_12
(2022) · Elsevier eBooks · doi:10.1016/b978-3-437-23673-0.00005-7
Bibliography: Psychopharmacology: Evidence and Treatments
(2014) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.12.2.184
Allgulander, C., & Nutt, D. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_113
Self-citationSedative, Hypnotic, and Anxiolytic Dependence
Stein, D. J. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_330
Sedative, Hypnotic, and Anxiolytic Dependence
Stein, D. J. (2014) · Springer eBooks · doi:10.1007/978-3-642-27772-6_330-2
Pharmacist interventions to deprescribe benzodiazepines in older adults: A missed opportunity?
Cadogan, C. A. (2022) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2022.05.012
Opioids: what can be done about long-term prescribing?
(2022) · Pharmaceutical journal/The pharmaceutical journal · doi:10.1211/pj.2022.1.145544 · Cited by 1
Legal and illegal drugs: Considerations for psychological treatment
Svanberg, J. (2014) · Clinical Psychology Forum · doi:10.53841/bpscpf.2014.1.264.21
Cheung, S., O’Beirne, M., Hill, T. R., Huyghebaert, T., Keller, S., & Kelly, M. A. (2023) · CMAJ Open · doi:10.9778/cmajo.20220080
Bottaro, G. B., Ferreira, L. B., Guimarães, R. B., Santos, R., & Goncalves, R. R. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n5-007
Hypnotic Dependence and Withdrawal
Brasil, I. S. P. S., & Hasan, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-50710-6_6
Durand, L., Keenan, E., O’Reilly, D., Bennett, K., O’Hara, A., & Cousins, G. (2023) · Figshare · doi:10.6084/m9.figshare.24264630
Pétein, C., Chevallereau, T., Aikpitanyi, J., Evrard, P., Tubeuf, S., Henrard, S., & Spinewine, A. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-085434 · Cited by 1
Evoked craving in high-dose benzodiazepine users
Zamboni, L., Benvegnù, G., Fusina, F., Vesentini, R., Locatelli, F., Mattiello, M., Mannari, V., Campagnari, S., Toldo, S., Congiu, A., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1562622
Health and Labor Market Consequences of Low-Value Care: The Role of Practice StylePreprint
Bakx, P., Mazzonna, F., & Albertini, M. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5166533
Kauye, F., Wijesundara, A., & Mwandumba, D. (2025) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/0117450179375369250623061653
Phantosmia and Benzodiazepine Withdrawal: A Case Report
Kiyokawa, M., Fong, S. R., & Cape, M. C. (2025) · Cureus · doi:10.7759/cureus.92116
Locked in syndrome by benzodiazepine poisoning
Arif, A., Fareedullah, M., Razzak, M. M. U., Haq, M. M. U., & Almas, J. (2025) · The Egyptian Journal of Critical Care Medicine · doi:10.1007/s44349-025-00033-1
Stein, D. J., Kazdin, A. E., Baldwin, D. S., Harris, M., Hwang, I. H., Pozuelo, J. R., Sampson, N. A., Woodruff, P. W. R., Viana, M. C., Aguilar‐Gaxiola, S., et al. (2025) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.70031
Self-citationLiu, R., Wu, Z., Yin, Y., Song, C., Zhang, C., Xing, S., Tan, J., Fu, Z., Wong, N. L., Deng, M., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121185 · Cited by 1
Rukbah, W. S. A., Vadlamudi, N. B., Garrett, S., Alshammari, S., & Wijesinghe, D. S. (2026) · medRxiv · doi:10.64898/2026.01.21.26344597
Hamadieh, Z., Goldfarb, D. G., & Ellendon, N. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07931-3
Cone, A., Zuzick, S., Durinski, T., Yates, E., Simonian, N., & Reggente, N. (2026) · npj Digital Medicine · doi:10.1038/s41746-026-02555-z
Benzodiazepine use : a two-way relationship with work accidents and impact of COVID-19 pandemic
Baudot, F.-O. (2022) · theses.fr (ABES) · doi:10.70675/88942d7fzaddbz4b8cz91b9zcc0b92de1598
Love, E. S. H., Jónsdóttir, F., & Sigurdsson, M. I. (2026) · Scientific Reports · doi:10.1038/s41598-026-49262-z
Drugs for anxiety: from chloral hydrate to novel therapeutics
Haddad, P. M. (2026) · The British Journal of Psychiatry · doi:10.1192/bjp.2026.10598
Ram, A., & Kadam, P. (2026) · i-manager s Journal on Life Sciences · doi:10.26634/jls.5.1.1135
da Silva, A. M. P., Leite, M. G. H. S. J., Menegucci, G., Negreli, M. F. L. A., Valverde, M. E. S., Menezes, I. R., Gonçalves, O. R., Lapa, J. D. D. S., Noleto, G. S., Santos, D. H., et al. (2026) · Drugs & Aging · doi:10.1007/s40266-026-01310-z
Quint, P., Schmidt, P.-M., Mackert, S., Aslan, B., Guth, M., von der Emde, L., Lechtenboehmer, R., Faßbender, K., Baumert, P. M., Stoffel‐Wagner, B., et al. (2026) · Human Brain Mapping · doi:10.1002/hbm.70598
Kazman, B. S. M. A., Muddapur, U. M., Shirolkar, S., Madhumala, Y., Shalavadi, M. H., Alqahtani, O. S., Alshamrani, M. A., Aljaezi, I., Shaikh, I. A., Khan, A. A., et al. (2026) · Journal of King Saud University - Science · doi:10.25259/jksus_1903_2025
Therapie und Prävention psychischer Störungen
Hengartner, M. P. (2026) · Angewandte Psychologie Kompakt · doi:10.1007/978-3-662-72845-1_5
Fármacos de uso más habitual en la patología psiquiátrica infanto-juvenil
Aparicio, T. J. (2026) · Boletín de Pediatría · doi:10.63788/b3pzty92
Ortega-Susín, M. J., Pérez, T., Serrano, D. R., & González‐Burgos, E. (2026) · Public Health · doi:10.1016/j.puhe.2026.106490
Anxiolytic Potential of Selected Essential Oils and Their Impact on Motor Function
Sá, A., Ogbu, J. I., Olusola, A. J., Afolabi, S., Pedrino, G., Ferreira-Neto, M. L., Aprigliano, V., Couto, R. O. D., de Carvalho, L. B. R., Borges, L. L., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198786
Prescriptions of Psychopharmaceuticals in High-Security Hospitals
Jeandarme, I., & Goktas, G. (2026) · International Journal of Forensic Mental Health · doi:10.1177/14999013261498236
Metadata
- Authors
- Baldwin, D. S., Aitchison, K., Bateson, A., Curran, H. V., Davies, S., Leonard, B., Nutt, D. J., Stephens, D. N., & Wilson, S.
- Affiliations
- University of Southampton (GB)
- University of Alberta (CA)
- Ross University School of Medicine (BB)
- University College London (GB)
- Centre for Addiction and Mental Health (CA)
- Ollscoil na Gaillimhe – University of Galway (IE)
- Imperial College London (GB)
- University of Sussex (GB)
- Corresponding author
- Baldwin, David S
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2013-09-24
- Volume
- 27
- Issue
- 11
- Pages
- 967-971
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2116273170
- Cited by
- 249
- References
- 7
- Citations by year
- 2026: 17 · 2025: 19 · 2024: 14 · 2023: 21 · 2022: 21 · 2021: 22 · 2020: 23 · 2019: 21 · 2018: 21 · 2017: 19 · 2016: 19 · 2015: 16 · 2014: 15
- FWCI
- 22.52
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Research Bank (Australian Catholic University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- benzodiazepines, anxiolytics, hypnotics, benzodiazepine dependence, long-term benzodiazepine use, benefits and risks, clinical guidelines, anxiety disorders, insomnia
- MeSH terms
- Benzodiazepines, Humans, Hypnotics and Sedatives, Practice Guidelines as Topic, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
